Cargando…
Inhibition of Receptor for Advanced Glycation End Products as New Promising Strategy Treatment in Diabetic Retinopathy
BACKGROUND: Extensive intracellular and extracellular formation of advanced glycation end-products (AGEs) is considered a causative factor for vascular injury triggered by hyperglycemia in diabetes. The hyperglycemia will cause accumulation of AGEs, damage to pericytes, nerve growth factor (NGF), gl...
Autores principales: | Saleh, Irsan, Maritska, Ziske, Parisa, Nita, Hidayat, Rachmat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Republic of Macedonia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061394/ https://www.ncbi.nlm.nih.gov/pubmed/32165929 http://dx.doi.org/10.3889/oamjms.2019.759 |
Ejemplares similares
-
Evaluation of the anti-gout effect of Sonchus Arvensis on monosodium urate crystal-induced gout arthritis via anti-inflammatory action - an in vivo study
por: Parisa, Nita, et al.
Publicado: (2021) -
Genipin relieves diabetic retinopathy by down-regulation of advanced glycation end products via the mitochondrial metabolism related signaling pathway
por: Sun, Ke-Xin, et al.
Publicado: (2023) -
Danger-associated molecular pattern molecules and the receptor for advanced glycation end products enhance ANCA-induced responses
por: Page, Theresa H, et al.
Publicado: (2021) -
Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
por: Leung, Christopher, et al.
Publicado: (2016) -
Differential Expression of Soluble Receptor for Advanced Glycation End-products in Mice Susceptible or Resistant to Chronic Colitis
por: Bramhall, Michael, et al.
Publicado: (2020)